Novartis’ Ultibro Breezhaler reduces lung hyperinflation in COPD patients

Treatment with Novartis’ Ultibro Breezhaler significantly boosted lung and cardiac function in chronic obstructive pulmonary disease (COPD) patients with lung hyperinflation, trial findings show.

• Source: Pharmatimes
• 613
• February 24, 2018